The funding highlights how service robotics is shifting from niche deployments to scaled commercial use across global markets
Updated
April 24, 2026 2:26 PM
An autonomous service robot with a cat face design standing inside a McDonalds restaurant. PHOTO: ADOBE STOCK
Pudu Robotics, a Shenzhen-based startup building robots for commercial environments, has raised nearly US$150 million in a new funding round, pushing its valuation past US$1.5 billion. The raise brings the company’s total funding to more than US$300 million.
The company focuses on service robotics across sectors such as delivery, cleaning and industrial logistics. Its systems are used in places like retail stores, warehouses and public venues where routine tasks can be automated. Over time, Pudu has expanded from single-purpose machines to a broader portfolio that combines hardware with AI-driven navigation and coordination.
The funding is expected to support several areas of growth. These include further development of its AI systems, expansion of its product range and continued international rollout. The company also plans to invest in manufacturing and supply chain capacity, suggesting a focus on scaling production alongside demand.
Pudu’s recent growth provides some context for the raise. The company reported a doubling of revenue by 2025, with its cleaning robots now accounting for the majority of its business. Its industrial delivery robots have also seen early traction, with thousands of units deployed within a year of launch.
Its products are already in use with large global retailers including Carrefour, Walmart and EDEKA. Industry estimates place Pudu among the largest players in commercial service robotics, with a leading share of the global market.
Technically, the company develops much of its core stack in-house, including navigation systems, multi-robot coordination software and motion control. This allows its robots to operate in complex real-world environments where multiple machines need to move and work together.
“This financial milestone is a powerful confirmation of Pudu’s industry leadership, the strength of its products and technology, its global brand, and its commercial infrastructure. With the support of our strategic investors and industry partners, Pudu will continue to push the boundaries of embedded AI and business service robotics. We remain committed to innovating with an inventor’s spirit and leveraging a global vision to accelerate robot adoption, thereby elevating the industry to new heights in the global value chain”. said Felix Zhang, founder and CEO of Pudu Robotics.
The funding round points to a broader shift in the sector. As service robotics moves from pilot deployments to wider adoption, companies are increasingly being judged on their ability to scale production and operate across markets, not just on the novelty of their technology.
Keep Reading
Reimagining biodefense at the intersection of AI, biology and urgency.
Updated
January 8, 2026 6:34 PM
Through computational tools, Valthos analyzes biological data to design adaptive solutions against emerging threats. PHOTO: VALTHOS
Valthos has raised US$30 million in seed funding, led by the OpenAI Startup Fund, Lux Capital and Founders Fund, to advance its mission of building next-generation biodefense systems.
The company’s work comes at a time when biotechnology is evolving at an unprecedented pace. Biotechnology is moving at record speed. These new tools can lead to life-changing medical discoveries, but they also bring the risk of dangerous biological agents being developed faster than ever.
“The issue at the core of biodefense is asymmetry”, said Kathleen McMahon, co-founder of Valthos. “It’s easier to make a pathogen than a cure. We’re building tools to help experts at the frontlines of biodefense move as fast as the threats they face”. The gap Valthos aims to close is between the rapid rise of biological threats and the slower pace of developing cures. Therefore, the company is developing AI systems that can rapidly analyze biological sequences and significantly shorten the time needed to design medical countermeasures.
“In this new world, the only way forward is to be faster. So we set out to build a new tech stack for biodefense”, said Tess van Stekelenburg, co-founder of Valthos. “This software infrastructure strengthens biodefense today and lays the groundwork for the adaptive, precision therapeutics of tomorrow”.
The company was founded by van Stekelenburg, a partner at Lux Capital and McMahon, the former head of Palantir’s Life Sciences division. Together, they’ve built a multidisciplinary team of experts from Palantir, DeepMind, Stanford’s Arc Institute and MIT’s Broad Institute, bringing together deep experience in software engineering, machine learning and biotechnology.
“Technology is moving fast. An industrial ecosystem of builders, companies and solutions further democratizes AI to provide broad resilience, and ensures the U.S. continues to lead as AI increasingly powers everything around us. As AI and biotech rapidly advance, biodefense is one of the new industry verticals that helps maximize the benefits and minimize the risks”, said Jason Kwon, OpenAI’s Chief Strategy Officer. “Valthos is pushing the frontier of protection and defense in one of the most strategic intersections of multiple world-changing technologies, and with the team to do it”.
Looking ahead, Valthos plans to expand its engineering team and scale its software infrastructure for both government and commercial partners — moving closer to its goal of enabling faster, smarter and more adaptive biodefense capabilities.